ADCYAP1 and Parkinson disease: Although previous PACAP-related drug discovery efforts have elucidated important factors that determine receptor activation and selectivity, none of these SAR studies investigated the effects of glycosylation for enhancing PACAP’s PK/PD and BBB transport properties in vitro and in vivo.